Patents-Review.com
ClassID:

21463 ⎘

A61K49/0438 - CPC Classification

Classification description:

Preparations for testing; X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol

Recent Application in this class:
#1
20260144909
2026-05-28

TETRAFLUOROETHYLENE COPOLYMER COMPOSITIONS AND ASSOCIATED METHODS

 #2
20260108671
2026-04-23

METHODS OF RETRIEVING CONTRAST MEDIA

 #3
20260007780
2026-01-08

LIQUID VEHICLE FORMULATION FOR ENTEROGRAPHY EXAMINATION

 #4
20260007779
2026-01-08

CT CONTRAST AGENT FOR DETECTION OF CACHEXIA

 #5
20250387530
2025-12-25

RADIOPAQUE MONOMER AND EMBOLISATION MICROSPHERES COMPRISING SAME

 #6
20250360232
2025-11-27

NANOCARBON-IODINE CALCIUM ALGINATE MICROSPHERES AND PREPARATION METHOD AND APPLICATION THEREOF

 #7
20250311587
2025-10-02

VASCULAR EMBOLIC SYSTEM

 #8
20250295816
2025-09-25

RADIOPAQUE AMINO-FUNCTIONAL CROSSLINKING AGENTS FOR MEDICAL APPLICATIONS

 #9
20250295778
2025-09-25

MATERIALS AND METHODS FOR REPEATABLE MAGNETIC NANOPARTICLE-BASED HEATING FOR TUMOR ABLATION

 #10
20250288727
2025-09-18

COMPOSITIONS FOR TREATMENT OF DISCOGENIC PAIN, AND PROCESSES FOR MAKING AND USING THE SAME

 #11
20250262147
2025-08-21

ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN

 #12
20250249130
2025-08-07

RADIOPAQUE POLYPEPTIDES FOR INJECTABLE COMPOSITIONS

 #13
20250205368
2025-06-26

Intrathecal Delivery of Recombinant Adeno-Associated Virus 9

 #14
20250177577
2025-06-05

RADIOPAQUE NANOPARTICLES FOR MEDICAL IMAGING

 #15
20250121099
2025-04-17

CLOSO-DODECAIODODECABORATE COMPLEXES AND METHODS OF USE FOR SAME

 #16
20250090664
2025-03-20

PIEZOELECTRIC SHEAR-THINNING MATERIAL COMPOSITIONS AND METHODS FOR USE

 #17
20250082400
2025-03-13

CHEMICAL ABLATION FORMULATIONS AND METHODS OF TREATMENTS FOR VARIOUS DISEASES

 #18
20250049730
2025-02-13

ULTRA SMALL GELATIN NANOPARTICLES, COMPOSITE STRUCTURES AND SYNTHESIS METHOD

 #19
20240415790
2024-12-19

A COMPOSITION FOR USE IN THE TREATMENT OF INTERVERTEBRAL DISC HERNIATION

 #20
20240399028
2024-12-05

Compositions for treatment of discogenic pain, and processes for making and using the same

 #21
20240390403
2024-11-28

COMPOSITION AND METHODS FOR TREATING AN ANEURYSM

 #22
20240335574
2024-10-10

Lipid Emulsion Alginate Microspheres

 #23
20240335568
2024-10-10

RADIOPAQUE POLYSACCHARIDE HYDROGELS AND METHODS OF MAKING THE SAME

 #24
20240325573
2024-10-03

X-RAY DEVELOPABLE MOLECULE, EMBOLISM MICROSPHERE AND PREPARATION METHODS THEREFOR

 #25
20240316220
2024-09-26

CATALYST-FREE RADIOPAQUE MEDICAL HYDROGELS AND SYSTEMS FOR FORMING SAME

 #26
20240293583
2024-09-05

RADIOPAQUE CROSSLINKED ACRYLAMIDE COPOLYMERS AND USES THEREOF

 #27
20240238454
2024-07-18

LUNG LESION LOCALIZATION MULTI-IMAGING CONTRAST AGENT COMPOSITION FOR RESTRICTIVE LUNG RESECTION

 #28
20240197336
2024-06-20

EMBOLIC COMPOSITIONS

 #29
20240115136
2024-04-11

Multiple CEST contrast imaging of nose-to-brain drug delivery using CT-contrast agent-loaded liposomes

 #30
20240082455
2024-03-14

EMBOLIC MATERIAL AND METHOD FOR PRODUCING THE SAME

 #31
20240000953
2024-01-04

CATIONIC NANOSTRUCTURES FOR INTRA-CARTILAGE DELIVERY OF CONTRAST AGENTS AND DIAGNOSTIC USES THEREOF

 #32
20230321284
2023-10-12

COMPOUND, CONTRAST AGENT, AND METHOD FOR PRODUCING COMPOUND

 #33
20230284994
2023-09-14

PET-CT IMAGING METHODS, CONTRAST AGENTS AND PHARMACEUTICAL COMPOSITIONS FOR USE IN SAID IMAGING METHODS

 #34
20230270489
2023-08-31

Chemical ablation formulations and methods of treatments for various diseases

 #35
20230190648
2023-06-22

Bioactive Tissue Derived Nanocomposite Hydrogels for Permanent Arterial Embolization and Enhanced Vascular Healing

 #36
20230149297
2023-05-18

Antibiotic formulations for lower back pain

 #37
20230147467
2023-05-11

Novel Contrast Agents and Imaging Methods for Early Detection of Diseases

 #38
20230099362
2023-03-30

LIQUID VEHICLE FOR ENTEROGRAPHY EXAMINATION

 #39
20230052363
2023-02-16

COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY

 #40
20220339299
2022-10-27

Vegetable oil-derived contrast agent with high stability and preparation method thereof

 #41
20220339285
2022-10-27

DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE

 #42
20220327706
2022-10-13

Method and apparatus for optimizing the use of contrast agents during medical imaging

 #43
20220313171
2022-10-06

Imaging and Treatment Methods for Early Detection of Diseases

 #44
20220168462
2022-06-02

VASCULAR EMBOLIC SYSTEM

 #45
20220160900
2022-05-26

CT CONTRAST AGENT FOR DETECTION OF CACHEXIA

 #46
20220142479
2022-05-12

Indicator fluids, systems, and methods for assessing movement of substances within, to or from a cerebrospinal fluid, brain or spinal cord compartment of a cranio-spinal cavity of a human

 #47
20220105249
2022-04-07

X-RAY AND MRI VISIBLE SHAPE MEMORY POLYMER BIOPSY SEALING DEVICE

 #48
20220096664
2022-03-31

STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS

 #49
20220016270
2022-01-20

Radiopaque monomers, polymers, microspheres, and methods related thereto

 #50
20210330820
2021-10-28

Nanoemulsion of iodinated fatty acids for CT imaging

 #51
20210330334
2021-10-28

Embolic compositions

 #52
20210321967
2021-10-21

Examination of a blood vessel based on nuclear resonant absorption

 #53
20210236660
2021-08-05

IMAGEABLE POLYMERS

 #54
20210228743
2021-07-29

Intrathecal delivery of recombinant adeno-associated virus 9

 #55
20210220487
2021-07-22

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9

 #56
20210186875
2021-06-24

MULTI-COMPONENT NANOCHAINS

 #57
20210154307
2021-05-27

CATIONIC NANOSTRUCTURES FOR INTRA-CARTILAGE DELIVERY OF THERAPEUTICS AND CONTRAST AGENTS

 #58
20210128454
2021-05-06

ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN

 #59
20210113173
2021-04-22

COMPUTED TOMOGRAPHY (CT) SYSTEM AND CT IMAGE RECONSTRUCTION METHOD

 #60
20210100918
2021-04-08

Intrathecal Delivery of Recombinant Adeno-Associated Virus 9

 #61
20210069352
2021-03-11

IODINE-BASED PARTICLES

 #62
20210015947
2021-01-21

CONTRAST MEDIUM FOR MICROANGIOGRAPHY

 #63
20200397766
2020-12-24

POROUS EMBOLIZATION MICROSPHERES COMPRISING DRUGS

 #64
20200390965
2020-12-17

Tailored dose of contrast agent

 #65
20200376143
2020-12-03

Methods for preserving a subject and using imaging contrast agents

 #66
20200375563
2020-12-03

Method for creating a three-dimensional digital subtraction angiography image and a C-arm X-ray device

 #67
20200323998
2020-10-15

Imaging agents and methods of using the same

 #68
20200315976
2020-10-08

Encapsulation Methods and Compositions

 #69
20200305816
2020-10-01

Method for providing image data of a hollow organ

 #70
20200282101
2020-09-10

BIODEGRADABLE TUMOR SEALANT

 #71
20200268776
2020-08-27

Emulsion composition for chemoembolization and method for producing same

 #72
20200254117
2020-08-13

Imageable polymers

 #73
20200215316
2020-07-09

Apparatus with Contrast-Coated Balloon and Methods

 #74
20200197541
2020-06-25

GEL FORMULATIONS FOR GUIDING RADIOTHERAPY

 #75
20200170509
2020-06-04

Indicator fluids, systems, and methods for assessing movement of substances within, to or from a cerebrospinal fluid, brain or spinal cord compartment of a cranio-spinal cavity of a human

 #76
20200155711
2020-05-21

Imageable embolic microsphere

 #77
20200009290
2020-01-09

Liquid embolic agent composition

 #78
20190388147
2019-12-26

Chemical ablation formulations and methods of treatments for various diseases

 #79
20190374439
2019-12-12

Kit and method for detecting porous dental hydroxyapatite

 #80
20190343761
2019-11-14

ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN

 #81
20190336618
2019-11-07

Intrathecal delivery of recombinant adeno-associated virus 9

 #82
20190328908
2019-10-31

IMAGEABLE EMBOLIC MICROSPHERE

 #83
20190314545
2019-10-17

Therapeutic agent for solid cancer

 #84
20190314345
2019-10-17

CALCINEURIN INHIBITOR AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG TO REDUCE RISK OF POST-IMAGING PANCREATITIS

 #85
20190307687
2019-10-10

Multi-component nanochains

 #86
20190307507
2019-10-10

Chemical ablation formulations and methods of treatments for various diseases

 #87
20190298862
2019-10-03

IOHEXOL POWDER AND METHOD OF USING THE SAME

 #88
20190298388
2019-10-03

Embolic compositions

 #89
20190275178
2019-09-12

Radiocontrast agents, scavenging methods, and scavenging system

 #90
20190269798
2019-09-05

Intrathecal delivery of recombinant adeno-associated virus 9

 #91
20190262474
2019-08-29

Intrathecal delivery of recombinant adeno-associated virus 9

 #92
20190247521
2019-08-15

Compositions and methods for reducing the risk of radiocontrast-induced nephropathy

 #93
20190231924
2019-08-01

Developable hyaluronic acid microspherical embolic agent, preparation method and use thereof

 #94
20190231908
2019-08-01

Radiopaque monomers, polymers, microspheres, and methods related thereto

 #95
20190201555
2019-07-04

Method of evaluating lymphatic system function

 #96
20190151477
2019-05-23

Intrathecal delivery of recombinant adeno-associated virus 9

 #97
20190134226
2019-05-09

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9

 #98
20190134225
2019-05-09

Intrathecal delivery of recombinant Adeno-associated virus 9

 #99
20190111159
2019-04-18

Imageable polymers

 #100
20190099503
2019-04-04

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9

 #101
20190054193
2019-02-21

Activity based probe and uses thereof for imaging

 #102
20190008973
2019-01-10

INTRALIPID-IODINE FOR IMAGING

 #103
20180360784
2018-12-20

X-RAY CONTRAST MEDIA COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT, REDUCE OR DELAY THE ONSET OF MIGRAINE

 #104
20180110885
2018-04-26

Compositions and methods for reducing the risk of post-imaging pancreatitis

 #105
20180104180
2018-04-19

THERMO-SENSITIVE BONE GROWTH COMPOSITIONS

 #106
20180055516
2018-03-01

Embolic compositions

 #107
20180030443
2018-02-01

NON-IONIC, LOW OSMOLAR CONTRAST AGENTS FOR DELIVERY OF ANTISENSE OLIGONUCLEOTIDES AND TREATMENT OF DISEASE

 #108
20170368205
2017-12-28

System and method for enhanced mass spectrometry imaging

 #109
20170360769
2017-12-21

Injectable anticancer composition for local administration containing suspension of quinine salt

 #110
20170274101
2017-09-28

Iodine-based particles

 #111
20170266325
2017-09-21

Compositions for nanoconfinement induced contrast enhancement and methods of making and using thereof

 #112
20170224849
2017-08-10

MICROCAPSULES AND USES THEREOF

 #113
20170216458
2017-08-03

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9

 #114
20170216206
2017-08-03

Multi-component nanochains

 #115
20170196777
2017-07-13

Kit and method for detecting porous dental hydroxyapatite

 #116
20170173189
2017-06-22

Liquid vehicle for enterography examination

 #117
20170035718
2017-02-09

Use of cilastatin to reduce the nephrotoxicity of different compounds

 #118
20160304440
2016-10-20

Purification of X-ray contrast agents

 #119
20160287744
2016-10-06

VASCULAR EMBOLIC SYSTEM

 #120
20160279269
2016-09-29

METHOD AND REAGENT FOR PREPARING A DIAGNOSTIC COMPOSITION

 #121
20160263251
2016-09-15

SYSTEMS AND METHOD OF DELIVERING FLUIDS TO A PATIENT OF VARYING CONCENTRATION

 #122
20160200670
2016-07-14

Radiopaque monomers, polymers, microspheres, and methods related thereto

 #123
20160193367
2016-07-07

Imageable polymers

 #124
20160184463
2016-06-30

Labeled ligands of anti-Mullerian hormone for diagnosis of endometriosis

 #125
20160089454
2016-03-31

Gel formulations for guiding radiotherapy

 #126
20160038599
2016-02-11

Biocompatible in situ hydrogel

 #127
20160030602
2016-02-04

Imageable embolic microsphere

 #128
20150366999
2015-12-24

Nanomagnetic modification of angiography contrast dye and a novel process for its removal using intravascular catheter based electromagnet system.

 #129
20150314020
2015-11-05

Compositions and methods using microspheres and non-ionic contrast agents

 #130
20150274645
2015-10-01

Preparation of intermediates of X-ray contrast agents

 #131
20150272666
2015-10-01

Chemical Ablation Formulations and Methods of Treatments for Various Diseases

 #132
20150265727
2015-09-24

Preparation of ioforminol, an x-ray contrast agent

 #133
20150251993
2015-09-10

Iohexol powder and method of using the same

 #134
20150250902
2015-09-10

pH-RESPONSIVE GADOLINIUM NANOPARTICLE CONJUGATES AND USES THEREOF

 #135
20150191422
2015-07-09

Contrast agents

 #136
20150190533
2015-07-09

X-ray imaging contrast media with low iodine concentration and X-ray imaging process

 #137
20150165042
2015-06-18

Biodegradable compositions suitable for controlled release

 #138
20150119706
2015-04-30

Biodegradable computed tomography contrast agents

 #139
20150110722
2015-04-23

Imageable polymers

 #140
20150037250
2015-02-05

CONTRAST AGENT

 #141
20140377185
2014-12-25

STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS

 #142
20140323552
2014-10-30

Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease

 #143
20140322139
2014-10-30

STABILIZATION OF X-RAY DIAGNOSTIC COMPOSITION

 #144
20140314678
2014-10-23

Compositions and methods using microspheres and non-ionic contrast agents

 #145
20140248213
2014-09-04

Compositions and methods for tumor imaging and targeting by a class of organic heptamethine cyanine dyes that possess dual nuclear and near-infrared properties

 #146
20140234225
2014-08-21

METHOD OF TREATMENT USING NANOPARTICULATE COMPOSITIONS HAVING LYSOZYME AS A SURFACE STABILIZER

 #147
20140227194
2014-08-14

Preparation for Restenosis Prevention

 #148
20140227193
2014-08-14

Preparation for Restenosis Prevention

 #149
20140227192
2014-08-14

Preparation for Restenosis Prevention

 #150
20140219924
2014-08-07

Medical tissue-marker and manufacturing method for the same

 #151
20140135397
2014-05-15

Halogenated phenols for diagnostics, antioxidant protection and drug delivery

 #152
20140134105
2014-05-15

Halogenated phenols for diagnostics, antioxidant protection and drug delivery

 #153
20140134102
2014-05-15

Fucoidans as ligands for the diagnosis of degenerative pathologies

 #154
20140065077
2014-03-06

CONTAINER WITH CONCENTRATED SUBSTANCE AND METHOD OF USING THE SAME

 #155
20140065076
2014-03-06

CONTAINER WITH CONCENTRATED SUBSTANCE AND METHOD OF USING THE SAME

 #156
20140046361
2014-02-13

Bioabsorbable co-filler for cerebrovascular aneurysms

 #157
20140005533
2014-01-02

Method for generating a contrast medium-assisted X-ray image and X-ray system

 #158
20140004051
2014-01-02

Co-crystals and salts of contrast agents and imaging

 #159
20130323181
2013-12-05

STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS

 #160
20130277221
2013-10-24

Desalination of a composition comprising a contrast agent

 #161
20130224123
2013-08-29

Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer

 #162
20130189187
2013-07-25

Nano-scale contrast agents and methods of use

 #163
20130164224
2013-06-27

CONTRAST MEDIUM COMPOSITION WITH CONTRAST ENHANCEMENT EFFECT BY COMPRISING HIGHLY CONCENTRATED CONTRAST AGENT

 #164
20130116554
2013-05-09

X-RAY IMAGING AT LOW CONTRAST AGENT CONCENTRATIONS AND/OR LOW DOSE RADIATION

 #165
20130108550
2013-05-02

Bioabsorbable Co-Filler for Cerebrovascular Aneurysms

 #166
20130101514
2013-04-25

Compositions and methods for treating nephropathy

 #167
20130071321
2013-03-21

DELIVERY OF AGENTS TO INFLAMED TISSUES USING FOLATE-TARGETED LIPOSOMES

 #168
20130045168
2013-02-21

Radiographic contrast agent for postmortem, experimental and diagnostic angiography

 #169
20130045164
2013-02-21

Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies

 #170
20130022549
2013-01-24

Halogenated phenols for diagnostics, antioxidant protection and drug delivery

 #171
20130018026
2013-01-17

HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY

 #172
20130017163
2013-01-17

HALOGENATED PHENOLS FOR DIAGNOSTICS, ANTIOXIDANT PROTECTION AND DRUG DELIVERY

 #173
20120328522
2012-12-27

Diagnostic composition comprising plasma cations having superior safety profile

 #174
20120276005
2012-11-01

CONJUGATES FOR DUAL IMAGING AND RADIOCHEMOTHERAPY: COMPOSITION, MANUFACTURING, AND APPLICATIONS

 #175
20120269727
2012-10-25

IMAGING AGENTS WITH IMPROVED PHARMACOKINETIC PROFILES

 #176
20120189552
2012-07-26

Compositions and methods using microspheres and non-ionic contrast agents

 #177
20120184642
2012-07-19

MULTIMODAL VISIBLE POLYMER EMBOLIZATION MATERIAL

 #178
20120183475
2012-07-19

Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies

 #179
20120177572
2012-07-12

Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies

 #180
20120134933
2012-05-31

USE OF HIGH-DOSES OF MONOMERIC CONTRAST MEDIUM CONTAINING IODINE IN X-RAY DIAGNOSTICS, IN PARTICULAR IN INTERVENTIONAL X-RAY DIAGNOSTICS AND IN RADIATION THERAPY ASSISTED BY CONTRAST MEDIA CONTAINING IODINE

 #181
20120076734
2012-03-29

RADIOPAQUE ANTIBIOTIC DENTAL PASTE AND USES THEREOF

 #182
20120039815
2012-02-16

Contrast agents

 #183
20110256068
2011-10-20

CONTRAST MEDIA COMPOSITIONS

 #184
20110165264
2011-07-07

Use of cilastatin to reduce nephrotatoxicity of various compounds

 #185
20110052504
2011-03-03

CONTRAST AGENTS

 #186
20110052503
2011-03-03

BIODEGRADABLE CONTRAST AGENTS

 #187
20110008263
2011-01-13

CONTRAST AGENTS

 #188
20100322868
2010-12-23

Contrast agents

 #189
20100303734
2010-12-02

CONTRAST AGENTS

 #190
20100284919
2010-11-11

Injectable Radio-Opaque Compositions for Tissue Augmentation

 #191
20100284510
2010-11-11

IMAGING GALLBLADDER USING COMPUTED TOMOGRAPHY

 #192
20100278997
2010-11-04

Preparation for restenosis prevention

 #193
20100278744
2010-11-04

Preparation for restenosis prevention

 #194
20100260685
2010-10-14

Contrast agents

 #195
20100221192
2010-09-02

CONTRAST AGENTS

 #196
20100221191
2010-09-02

CONTRAST AGENTS

 #197
20100221189
2010-09-02

Contrast agents

 #198
20100183508
2010-07-22

Radioactive mixture and manufacturing method thereof

 #199
20100135913
2010-06-03

Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics

 #200
20100055043
2010-03-04

Poly-Halo Metal X-ray Contrast Agents

 #201
20100021389
2010-01-28

Radiographic contrast agent for postmortem, experimental and diagnostic angiography

 #202
20090263326
2009-10-22

Nano-scale contrast agents and methods of use

 #203
20090252678
2009-10-08

COX-2-TARGETED IMAGING AGENTS

 #204
20090240142
2009-09-24

Systems and method of delivering fluids to a patient of varying concentration

 #205
20090209745
2009-08-20

Radiographic contrasting agents and radio-opaque polymeric materials for medical devices

 #206
20090098059
2009-04-16

CONTRAST AGENTS

 #207
20090074875
2009-03-19

Nanoparticulate compositions having lysozyme as a surface stabilizer

 #208
20090053142
2009-02-26

Contrast agents

 #209
20090047218
2009-02-19

Method for producing albumin conjugates comprising an X-ray contrast medium as the active substance

 #210
20080317675
2008-12-25

Low osmolar X-ray contrast media formulations

 #211
20080267884
2008-10-30

Contrast Agents and Diagnostic Compositions Based on Iodine-Containing Cyanuric Acid Derivatives

 #212
20080260651
2008-10-23

CONTRAST AGENTS

 #213
20080219931
2008-09-11

Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies

 #214
20080199403
2008-08-21

Composition and Method for Direct Visualization of the Human Appendix

 #215
20080131369
2008-06-05

Compositions And Methods For Enhancing Contrast In Imaging

 #216
20080107709
2008-05-08

RADIO-OPAQUE POLYMERIC BIOMATERIALS

 #217
20080102034
2008-05-01

PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS

 #218
20080102033
2008-05-01

PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS

 #219
20080095704
2008-04-24

Imaging Agents with Improved Pharmacokinetic Profiles

 #220
20070212303
2007-09-13

Compositions and methods for enhancing contrast in imaging

 #221
20070196277
2007-08-23

Compositions and Methods for the Direct Therapy of Tumors

 #222
20070134163
2007-06-14

Radiographic contrasting agents and radio-opaque polymeric materials for medical devices

 #223
20070123478
2007-05-31

COMPOSITIONS USEFUL FOR REDUCING NEPHROTOXICITY AND METHODS OF USE THEREOF

 #224
20070088087
2007-04-19

Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions

 #225
20070081941
2007-04-12

F-18 Labeled Amino Acid Analogs

 #226
20060251583
2006-11-09

DTPA derivatives and metal complexes thereof, and radiation source and contrast agent including the metal complexes

 #227
20060251582
2006-11-09

Compositions and methods using microspheres and non-ionic contrast agents

 #228
20060251577
2006-11-09

Composition and method for direct visualization of the human appendix

 #229
20060204440
2006-09-14

Radio-opaque polymeric biomaterials

 #230
20060182687
2006-08-17

Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications

 #231
20060154989
2006-07-13

Trimeric, macrocyclically substituted halo-benzene derivatives

 #232
20060127306
2006-06-15

Radioactively labelled amino acid analogues, their preparation and use

 #233
20060120965
2006-06-08

Trimeric, macrocyclically substituted aminoisophthalic acid-halo-benzene derivatives

 #234
20060120956
2006-06-08

Imaging agents comprising barbituric acid derivatives

 #235
20060073101
2006-04-06

Method for convection enhanced delivery of therapeutic agents

 #236
20060002858
2006-01-05

Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions

 #237
20050281746
2005-12-22

Anticoagulant contrast media

 #238
20050250672
2005-11-10

Preparation for the prophylaxis of restenosis

 #239
20050238584
2005-10-27

Compositions and methods for enhancing contrast in imaging

 #240
20050180920
2005-08-18

Oral contrast media composition for computerized axial tomographic examinations and method

 #241
20050123481
2005-06-09

Radio-opaque polymeric biomaterials

 #242
20050119746
2005-06-02

Bioresorbable bone mineral substitute comprising water-soluble X-ray contrast agent

 #243
20050101522
2005-05-12

Preparation for the prophylaxis of restenosis

 #244
20050084453
2005-04-21

Liposome-containing radiographic contrast medium and preparation method thereof

 #245
20050002859
2005-01-06

COX-2-targeted imaging agents

 #246
14174126
2017-03-07

Palatable liquid dilution vehicles for oral contrast agents